mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.2 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.031 |
0.5 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.08 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.1 |